NNNN
Anbio Biotechnology
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| F-3ASR | 7/9/2026 | View on SEC |
| 3 | 6/12/2026 | View on SEC |
| 3 | 6/12/2026 | View on SEC |
| 6-K | 5/19/2026 | View on SEC |
| 6-K | 4/27/2026 | View on SEC |
| 20-F/A | 4/9/2026 | View on SEC |
| 3 | 4/8/2026 | View on SEC |
| 3 | 4/8/2026 | View on SEC |
| 3 | 4/8/2026 | View on SEC |
| 3 | 4/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NNNN |
| Company Name | Anbio Biotechnology |
| CIK | 1982708 |
| Sector | In Vitro & In Vivo Diagnostic Substances |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 4916096247281 |